Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

SHG:600332 China Medical Distribution
Market Cap
$4.88 Billion
CN¥35.79 Billion CNY
Market Cap Rank
#3915 Global
#353 in China
Share Price
CN¥25.46
Change (1 day)
+0.32%
52-Week Range
CN¥24.92 - CN¥27.59
All Time High
CN¥41.57
About

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials. The company operates through Great Southern TCM, Great Commerce, Great Health, and Other segments. It is also involved in the wholesale, retail, sale, … Read more

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.043x

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a cash flow conversion efficiency ratio of 0.043x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.73 Billion) by net assets (CN¥39.98 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2024)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥37.77 Billion CN¥3.44 Billion 0.091x -18.54%
2023-12-31 CN¥36.68 Billion CN¥4.10 Billion 0.112x -46.23%
2022-12-31 CN¥33.64 Billion CN¥7.00 Billion 0.208x +14.89%
2021-12-31 CN¥31.33 Billion CN¥5.67 Billion 0.181x +772.92%
2020-12-31 CN¥28.21 Billion CN¥585.19 Million 0.021x -89.26%
2019-12-31 CN¥25.99 Billion CN¥5.02 Billion 0.193x -14.27%
2018-12-31 CN¥23.14 Billion CN¥5.22 Billion 0.225x +136.80%
2017-12-31 CN¥19.26 Billion CN¥1.83 Billion 0.095x -31.26%
2016-12-31 CN¥17.65 Billion CN¥2.44 Billion 0.138x -38.08%
2015-12-31 CN¥8.68 Billion CN¥1.94 Billion 0.224x +1.05%
2014-12-31 CN¥7.96 Billion CN¥1.76 Billion 0.221x +16.05%
2013-12-31 CN¥7.02 Billion CN¥1.34 Billion 0.191x +59.04%
2012-12-31 CN¥4.22 Billion CN¥506.53 Million 0.120x +359.40%
2011-12-31 CN¥3.90 Billion CN¥-180.05 Million -0.046x -330.06%
2010-12-31 CN¥3.64 Billion CN¥73.17 Million 0.020x -84.45%
2009-12-31 CN¥3.40 Billion CN¥439.39 Million 0.129x +6725.17%
2008-12-31 CN¥3.22 Billion CN¥6.10 Million 0.002x -98.34%
2007-12-31 CN¥3.29 Billion CN¥375.74 Million 0.114x +766.65%
2006-12-31 CN¥2.95 Billion CN¥38.88 Million 0.013x -74.75%
2005-12-31 CN¥2.81 Billion CN¥146.32 Million 0.052x -31.47%
2004-12-31 CN¥2.64 Billion CN¥200.54 Million 0.076x +2991.17%
2003-12-31 CN¥2.60 Billion CN¥-6.83 Million -0.003x -103.77%
2002-12-31 CN¥2.42 Billion CN¥169.01 Million 0.070x +13.67%
2001-12-31 CN¥2.28 Billion CN¥140.15 Million 0.061x -67.96%
2000-12-31 CN¥1.50 Billion CN¥286.95 Million 0.192x --